LYFAX Holdings Information

LYFAX is a mutual fund with a total of 62 individual holdings. The top holdings are Gilead Sciences stock at 5.53%, Vertex Pharmaceuticals at 5.33%, AstraZeneca at 4.63%, First American Treasury Obligs X at 4.26%, and Roivant Sciences at 3.67%.

Total Holdings

Top 10 Percentage

40.74%

Asset Class

Equity

Fund Category

Health

Assets

47.20M

Forward PE Ratio

n/a

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	5.53%	20,426
2	VRTX	Vertex Pharmaceuticals Incorporated	5.33%	5,002
3	LON: AZN	AstraZeneca PLC	4.63%	11,394
4	FXFXX	First American Treasury Obligs X	4.26%	1,985,519
5	ROIV	Roivant Sciences Ltd.	3.67%	48,355
6	ARGX	argenx SE	3.59%	1,806
7	NBIX	Neurocrine Biosciences, Inc.	3.51%	9,727
8	INCY	Incyte Corporation	3.51%	14,451
9	AXSM	Axsome Therapeutics, Inc.	3.43%	6,531
10	APGE	Apogee Therapeutics, Inc.	3.28%	11,533
11	IONS	Ionis Pharmaceuticals, Inc.	2.62%	15,430
12	ASND	Ascendis Pharma A/S	2.62%	4,585
13	INSM	Insmed Incorporated	2.60%	11,394
14	PTGX	Protagonist Therapeutics, Inc.	2.41%	9,171
15	PSNL	Personalis, Inc.	2.27%	78,924
16	RYTM	Rhythm Pharmaceuticals, Inc.	2.25%	9,449
17	ABBV	AbbVie Inc.	1.95%	3,613
18	JAZZ	Jazz Pharmaceuticals plc	1.87%	3,613
19	AMGN	Amgen Inc.	1.83%	2,362
20	BIIB	Biogen Inc.	1.80%	3,891
21	CPRX	Catalyst Pharmaceuticals, Inc.	1.59%	23,622
22	HALO	Halozyme Therapeutics, Inc.	1.58%	9,426
23	MGTX	MeiraGTx Holdings plc	1.58%	54,469
24	KRYS	Krystal Biotech, Inc.	1.55%	1,945
25	NUVL	Nuvalent, Inc.	1.47%	5,558

Showing 25 of 62 holdings

Subscribe to see the full list

Activate Now

As of Jun 30, 2026